Navigation Links
Volcano Corp Announces First Human Use of the Volcano Optical Coherence Tomography (OCT) Imaging Catheter
Date:5/8/2008

asis continues to be focused around 'Choice', the ability for Volcano to provide a number of different therapy enabling modalities, and letting the physician choose which technology is appropriate for each individual patient."

Christopher E. Banas, Vice President and General Manager of Volcano's OCT Division in San Antonio Texas, and former CEO and Chairman of CardioSpectra commented, "This is an important step in demonstrating the ability of Volcano's OCT catheter to safely image coronary vessels of human patients and establishing a leadership position in advanced coronary imaging technologies."

Volcano's OCT imaging platform provides high-resolution images in the 10- 15 micron range, opening the door for new applications to complement both IVUS and angiography. Michel Lussier, president of Volcano Europe commented, "The high resolution OCT images provide a glimpse at structural detail not seen before by other imaging modalities. We believe that OCT has the potential to identify thin-cap fibro-atheromas, clearly highlight intraluminal thrombus, and assess the complete healing of novel drug-eluting stent designs. Volcano is committed to exploring the various clinical benefits of our OCT platform through detailed data-driven study design and mutually beneficial partnerships with other therapy companies."

Patrick Serruys, M.D., commented, "The Volcano OCT Imaging Catheter is another step closer to delivering interventionalists with the true cath lab of the future. To better serve my patients, I want the flexibility to select from an array of different tools, quickly interrogate the vessel, and immediately process the information. Having these various technologies, including IVUS, OCT and FFR, all integrated into the lab, with a common user interface, review points, data storage and staff training provides this flexibility."

About Volcano Corporation

Volcano Corporation (NASDAQ:

SOURCE Volcano Corporation
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related biology technology :

1. Volcano Corporation Presentation at Bear Stearns Conference to be Webcast
2. Volcano Corporation Announces Pricing of Common Stock Offering
3. Volcano Announces Activities at TCT 2007: Expanded Role of IVUS in PCI to be Demonstrated
4. Volcano Announces Closing of CardioSpectra Acquisition
5. Volcano Corporation Schedules Fourth Quarter Conference Call, Webcast
6. Volcano Announces FDA 510(k) Clearance of Revolution Rotational Catheter and FFR for the s5i Integrated IVUS Console
7. Volcano Corporation Presentation at Cowen Healthcare Conference to be Webcast
8. Volcano Announces U.S. and European Launch of Rotational IVUS and Integrated FFR
9. Volcano Reports 24 Percent Increase in First Quarter Revenues; IVUS Disposable Revenues Increase 30 Percent
10. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
11. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2008)...FirstCall/ -- AstraZeneca (NYSE:,AZN) today announ...A) has,approved once-daily SEROQUEL XR(R) (quetiap...te treatment of the depressive episodes associated...es associated with bipolar I,disorder, and the mai...tive,therapy to lithium or divalproex. SEROQUEL XR...
(Date:10/10/2008)...Takeda Pharmaceutical Company,Limited ("Takeda") t...elopment Center, Inc., a wholly owned United State...e U.S. Food and Drug Administration (FDA) will,not...New Drug Application,(NDA) by the Prescription Dru... "In our most recent discussion with the FDA, it i...
(Date:10/9/2008)...up six spots from last year, ST. LOUIS, Oct. 9 /P...N) is earning recognition as a leader in biotechno... also for being a great place to work., Monsanto,... place in,the 2008 Top Biotech and Pharma Employer... The company moved up six spots from number eight ...
(Date:10/9/2008)... - Dr. Brad Thompson, President,and CEO of Oncolyt...esent a,corporate overview of the Company at the 1...on, U.K. on Monday, October 13 at 2 p.m. The confe...nference Centre from October,12-14, 2008., About ...based biotechnology company focused on the,develop...
Breaking Biology Technology:FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 2FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 3FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 4FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 5FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 6FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 7FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 8FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 9FDA Continues Review of Takeda's New Drug Application for Alogliptin (SYR-322), a DPP-4 Agent for Type 2 Diabetes 2Monsanto Recognized as Top Biotechnology Employer by Science Magazine 2Media Advisory - Oncolytics Biotech Inc. to Present at BioPartnering Europe 2
... stories to tell, but perhaps nothing is more illu...ory of a little girl drawing in the back of a clas...ul Getty Trust in Los Angeles and an internationa..., told the story during a keynote address at the a...Association Conference. , ,Noting that young chil...
...ago Bar Association entitled "Communication Rights...t Century." At that time, many who attended thou...faith in it. My argument was that the horse-and-bu...d liquor were maxed out. Municipalities would have...ms that could pay for services and pensions. , ,Th...
...n Internet data provider, has appointed its legal ...ions officer. , ,Meier brings experience in the le...and he will be responsible for helping the Milwauk...and business development programs. , ,"I believe i...go when it was just two people and an idea," Donat...
...and his company through a series of mergers and pe...der of JT Packard & Associates, Inc. , Cason pres...er. The company has grown by 500 percent over the ...ptible power supply (UPS) service company in the c...,With its recent purchase by Anaheim, Calif.-based...
Other Biology Technology:Sir Ken Robinson: Companies, kids "get" innovation, but K-12 doesn't nurture it 2Sir Ken Robinson: Companies, kids "get" innovation, but K-12 doesn't nurture it 3Creativity, innovation extend to municipalities 2Creativity, innovation extend to municipalities 3Creativity, innovation extend to municipalities 4Power services firm JT Packard isn't through growing 2Power services firm JT Packard isn't through growing 3
(Date:10/10/2008)...ry researchers have found that statins may be able...g from pregnancy complications caused by antiphosp...ce. In this autoimmune syndrome, the body produces...mponents of cell membranes. This news comes from a...nal of Clinical Investigation that is currently o...
(Date:10/10/2008)...f Kyoto University and the Gladstone Institute of ...ep forward in improving the possibilities for the ...(iPS) cell technology. , Previously, Dr. Yamanak...o become embryonic stem celllike using a cancer-ca...o reprogram the cells, and a virus to transfer the...
(Date:10/10/2008)..., Gasterosteus aculeatus , is one of the most tho...n a particularly useful model for understanding va...morphology caused by different ecological situatio...cular and genetic to developmental and morphologic...it has proven far more complex than even imagined....
(Date:10/10/2008)... in German . , DNA, the molecule that acts as...f life, is highly resistant against alteration by ... for its photostability presents some puzzling pro... four chemical bases that make up the DNA molecule... showing that DNA strands differ in their light se...
Breaking Biology News(10 mins):Statins may prevent miscarriages 2Statins may prevent miscarriages 3Yamanaka eliminates viral vector in stem cell reprogramming 2Fitness in a changing world 2Fitness in a changing world 3Can genetic information be controlled by light? 2Foamix and Galderma to Develop Medicated Foam for Certain Skin Diseases 1932 1Foamix and Galderma to Develop Medicated Foam for Certain Skin Diseases 1932 2Engineers harness cell phone technology for use in medical imaging 4950 1Engineers harness cell phone technology for use in medical imaging 4950 2Engineers harness cell phone technology for use in medical imaging 4950 3Engineers harness cell phone technology for use in medical imaging 4950 4Viscosity Enhancers Curb Bleeding Complications 17971 1Viscosity Enhancers Curb Bleeding Complications 17971 2Genes Linked to Osteoporosis Identified 17967 1Genes Linked to Osteoporosis Identified 17967 2Genes Linked to Osteoporosis Identified 17967 3
...f Medicine researchers have discovered how new neu...nt to regions of the brain where they can replace ...tem cell therapies can be specifically targeted to...ses or by stroke. , Associate Professor Qun-Yong Z...artment of Pharmacology have identified a protein ...
... the world are breathing a sigh of relief, as they...ir natural disease-fighting substances. Scientists... didemnii, which lives symbiotically inside the se...es, compounds that may one day be used in cancer t...s could not successfully cultivate Prochloron in t...
...sma protein found in blood, can be fused with larg...stimulating factor (G-CSF) to create a new oral co...rough the gastrointestinal (GI) tract and then abl... the body, according to research from the Universi...is technology may allow for oral administration of...
...factors prove that BioMed Central,s Open Access jo... Journals published by BioMed Central have again r...valent subscription titles, it was announced today...lty. The high impact factors for these journals af...re fast becoming the place for authors to submit i...
Other Biology News:Researchers discover stem cell 'guide' that may be key for targeting neural stem cell treatments 2Recombinant DNA technology may enable oral, rather than injectable, delivery of protein drugs 2Recombinant DNA technology may enable oral, rather than injectable, delivery of protein drugs 3'Bionic' arm gives amputee sense of touch 2
...itivity Laboratory Osmometer for both 0.2 and 2.0 ...ludes built-in printer, keypad, and software for s...reading capability with optional scanner. RS-232 p...Two-step Calibration. ...
MAb to Hu-IFN-Gamma RC2 (CD118), NON-Neutralizing, Clone MMHGR-2 Binds to but does not neutralize human interferon gamma receptor
Recombinant Rat CINC-2 alpha, CF
RAT ANTI MOUSE F4/80 ANTIGEN:BIOTIN Immunogen: Thioglycollate stimulated peritoneal macrophages from C57/BL mice
Biology Products: